Rigorous studies to build on earlier efforts to test the experimental treatmentContinue reading
Author Archive: AZBio
Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
– Primary endpoint of viral load change from baseline at day 11 was met for one of three doses; consistent effects of viral reduction seen at earlier time points
– Rate of hospitalizations and ER visits was 1.7 percent (5/302) for LY-CoV555 versus 6 percent (9/150) for placebo–a 72 percent risk reduction in this limited population
– LY-CoV555 was well-tolerated across all doses with no drug-related serious adverse events reported
INDIANAPOLIS, Sept. 16, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced proof of concept data from an interim analysis of the BLAZE-1 clinical trial, showing a reduced rate of hospitalization for patients treated with LY-CoV555. The randomized, double-blind, placebo-controlled Phase 2 study evaluated LY-CoV555, a SARS-CoV-2 neutralizing antibody, for the treatment of symptomatic COVID-19 in the outpatient setting. The trial enrolled mild-to-moderate recently diagnosed COVID-19 patients across four groups (placebo, 700 mg, 2800 mg, and 7000 mg).Continue reading
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
- Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatment –
- New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs
- More sensitive than traditional Pap cytology, this test allows clinicians to determine which HPV-positive women require further diagnostic procedures to prevent disease progression
Opportunity Alert: The 2021 application for the Flinn Foundation Bioscience Entrepreneurship Program is now open
$30K, professional connections, and support await six Arizona bioscience firmsContinue reading
Find funding, partners, companies, and jobs with new Bioscience Directory
A new comprehensive Bioscience Directory launched by the Flinn Foundation includes an interactive map with more than 1,000 companies and organizations and detailed resources for the people working to advance the biosciences in Arizona.Continue reading
Cancer Prevention Pharmaceuticals Announces NEJM Publication of Landmark Phase 3 Clinical Trial for Treatment of Familial Adenomatous Polyposis
Potential benefits seen for patients with intact colonsContinue reading
White Hat Life Science Investor Conference Creates Opportunities for Innovators and Investors
The White Hat Life Science Investor Conference, a biotech and healthcare investor conference, will showcase exciting biotech and medtech companies from across the Rocky Mountain & Southwest Region in an all digital format September 13 – 19, 2020 during Arizona Bioscience Week.
Investors and other attendees will have the opportunity to connect with a new generation of biotech and healthcare pioneers using virtual meetings via the Arizona Bioscience Week app.Continue reading
Biopharma Leaders Unite to Stand with Science
Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccinesContinue reading
Banner poison experts warn of dangerous social media challenge
Data shows teens encouraging each other to ‘Benadryl Challenge’. We see critically ill diphenhydramine (Benadryl®) poisoning quite frequently, including coma, seizures, cardiac toxicity, profound temperature elevations and death.Continue reading
Ivy Brain Tumor Center Appoints Shwetal Mehta, Ph.D., as Chief Operating Officer
The Ivy Brain Tumor Center at Barrow Neurological Institute, a nonprofit translational research program that offers state-of-the-art clinical trials for patients with aggressive brain tumors, announced that it has named Shwetal Mehta, Ph.D., as the organization’s chief operating officer.Continue reading